Cocoa Flavanols and Painfree Walking Distance
Long-term Effect of Dietary Intervention With Flavanol-containing Cocoa on Vascular Function of Diabetic Patients
1 other identifier
interventional
62
1 country
1
Brief Summary
To characterize potential vascular long-term effects of flavanols in patients with peripheral artery occlusive disease (PAOD), a placebo-controlled double-blinded randomized control study will be performed in 62 patients randomized in two groups. Patients will twice daily receive either a flavanol-poor cocoa drink or a flavanol-rich cocoa drink over a period of 60 days months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Oct 2009
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 5, 2010
CompletedFirst Posted
Study publicly available on registry
February 8, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedNovember 13, 2013
November 1, 2013
3.1 years
February 5, 2010
November 12, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
painfree walking distance
60 days
Secondary Outcomes (1)
endothelial function
60 days
Study Arms (2)
flavanol rich cocoa drink (596mg)
EXPERIMENTALdissolved in water, twice daily intervention
flavanol poor cocoa drink ( 13mg)
EXPERIMENTALdissolved in water, twice daily intervention
Interventions
dissolved in water twice-daily intervention
Eligibility Criteria
You may qualify if:
- peripheral artery disease (Fontaine IIb)
- diabetes mellitus
- \> 18 years
You may not qualify if:
- acute and terminal renal failure
- acute infection
- heart failure (NYHA III-IV)
- arrhythmias
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Heinrich Heine University
Düsseldorf, North Rhine-Westphalia, 40225, Germany
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christian Heiss, MD
Heinrich Heine University
- STUDY CHAIR
Malte Kelm, MD
Heinrich Heine University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Klinik für Kardiologie, Pneumologie und Angiologie
Study Record Dates
First Submitted
February 5, 2010
First Posted
February 8, 2010
Study Start
October 1, 2009
Primary Completion
November 1, 2012
Study Completion
December 1, 2012
Last Updated
November 13, 2013
Record last verified: 2013-11